Vical, Inc. (NASDAQ: VICL) is focused on the research and development of biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. The Company is developing certain infectious disease vaccines and cancer therapeutics internally, and collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. For further information, visit the Company’s Web site at www.vical.com.

Noble Financial, a research driven, full-service investment banking boutique, is as discriminating with its invitations to institutional investors as it is with the companies invited to present. Rather than just focusing on crowding the conference floor, Noble Financial carefully invites a smaller audience of investors with a large appetite for the companies presenting; quality always trumps quantity. For more information or to view webcasts of today’s presentations, visit www.noblefcm.com.

Let us hear your thoughts below: